NCT04629053 (SEACTN-WP-B) is a clinical trial in Acute Febrile Illness, sponsored by University of Oxford.

Who is sponsoring NCT04629053?

NCT04629053 is sponsored by University of Oxford.

What condition does NCT04629053 study?

NCT04629053 studies Acute Febrile Illness.

Is NCT04629053 still recruiting?

NCT04629053 is currently recruiting now. Last updated 12 January 2026.

Last reviewed 2026-01-12 · How we verify

NCT04629053: SEACTN-WP-B

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia

Recruiting now Last updated 12 January 2026

What this trial tests

trial in Acute Febrile Illness in 7,200 participants. Currently enrolling.

Timeline

21 June 2022

Primary endpoint
1 December 2026

1 December 2026

Quick facts

Lead sponsor	University of Oxford
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	7,200
Start date	21 June 2022
Primary completion	1 December 2026
Estimated completion	1 December 2026
Sites	4 locations across Bangladesh, Laos, Thailand

Conditions studied

Acute Febrile Illness — all drugs for Acute Febrile Illness →

Sponsor

University of Oxford

Who can join

29 Days and older, any sex, with Acute Febrile Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective multi-site observational study aims to describe causes and clinical outcomes of acute febrile illness as well as host biomarkers in patients aged \>28 days residing in rural areas in Laos, Myanmar, Thailand, the Thai-Myanmar border region, and Bangladesh and presenting with acute febrile illnesses (≤ 14 days duration) to participating health facilities. This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Febrile Illness

Currently open trials in the same condition.

NCT06822907 — Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults · Phase 4 · recruiting

Other University of Oxford trials

Trials by the same sponsor.

NCT05380388 — A Safety, Immunogenicity and Efficacy Study of PvRII/Matrix-M in Healthy Thai Adults Living in Thailand ( MIST3 ) · Phase 2 · not yet recruiting
NCT07470424 — A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults · Phase 1 · not yet recruiting
NCT07345910 — Environment, Pathogens, and Host Interactions in Melioidosis · not yet recruiting
NCT07434973 — Stratification and Treatment in Early Psychosis Study - PROMOTE · Phase 3 · not yet recruiting
NCT07460401 — 'Do Patient Characteristics Associate With Poor Outcome With Femoral Acetabular Impingement Syndrome (FAIS) Following Ph · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04629053 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Oxford
Last refreshed: 12 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04629053.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing